Corey N. Fishman - 23 Jun 2021 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Chief Executive Officer, Director
Signature
/s/ Corey N. Fishman
Issuer symbol
ITRM
Transactions as of
23 Jun 2021
Net transactions value
$0
Form type
4
Filing time
25 Jun 2021, 16:06:02 UTC
Next filing
15 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Stock Option (Right to Buy) Award $0 +5,280,000 $0.000000 5,280,000 23 Jun 2021 Ordinary Shares 5,280,000 $2.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of June 23, 2021 and the remaining 75% will vest in equal monthly installments thereafter until June 23, 2025, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date.